BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37138462)

  • 1. COVID-19 vaccination elicited
    Chen SP; Takizawa T; Sekiguchi K; Nakahara J; Wang SJ
    Cephalalgia; 2023 May; 43(5):3331024231173354. PubMed ID: 37138462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccination-triggered cluster headache episodes with frequent attacks.
    Brandt RB; Ouwehand RH; Ferrari MD; Haan J; Fronczek R
    Cephalalgia; 2022 Nov; 42(13):1420-1424. PubMed ID: 35833226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cluster headache after COVID-19 vaccination with Comirnaty: A signal in pharmacovigilance database.
    Rochoy M; Billy E; Clarot F; Dumortier V; Gautier S; Barus R
    Therapie; 2022; 77(6):753-754. PubMed ID: 35599191
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study.
    Sekiguchi K; Watanabe N; Miyazaki N; Ishizuchi K; Iba C; Tagashira Y; Uno S; Shibata M; Hasegawa N; Takemura R; Nakahara J; Takizawa T
    Cephalalgia; 2022 Mar; 42(3):266-272. PubMed ID: 34407651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
    Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
    Front Immunol; 2022; 13():956825. PubMed ID: 36177033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Questionnaire-based study of COVID-19 vaccination induced headache: evidence of clusters of adverse events.
    Zhou Q; Eggert T; Zhelyazkova A; Choukér A; Adorjan K; Straube A
    BMC Neurol; 2024 Mar; 24(1):84. PubMed ID: 38431578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccination-related headache showed two different clusters in the long-term course: a prospective multicenter follow-up study (COVA-Head Study).
    Atalar AÇ; Acarlı ANÖ; Baykan B; Martelletti P; Bolay H; Ertaş M; Ekizoğlu E; Karadaş Ö; Polat B; Gençdal IY; Azorin DG; Mitsikostas D; Apostolakopoulou L; Genç H; Dikmen PY; Demirel EA; Aydınlar EI; Gözübatık-Celik RG; Shafiyev J; Taşdelen B; Özge A
    J Headache Pain; 2023 Sep; 24(1):132. PubMed ID: 37773092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological aspects of headache after different types of COVID-19 vaccines: An online survey.
    Magdy R; Khedr D; Yacoub O; Attia A; Abdelrahman MA; Mekkawy D
    Headache; 2022 Sep; 62(8):1046-1052. PubMed ID: 36005277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective cohort study: is COVID-19 BNT162b2 mRNA vaccination a trigger factor for cluster headache?
    Aşkın Turan S; Aydın Ş
    Acta Neurol Belg; 2024 Apr; ():. PubMed ID: 38619748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headache following vaccination against COVID-19 among healthcare workers with a history of COVID-19 infection: a cross-sectional study in Iran with a meta-analytic review of the literature.
    Nasergivehchi S; Togha M; Jafari E; Sheikhvatan M; Shahamati D
    Head Face Med; 2023 May; 19(1):19. PubMed ID: 37202794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event Reporting System Database Analysis.
    Singh RB; Parmar UPS; Kahale F; Agarwal A; Tsui E
    Ophthalmology; 2023 Feb; 130(2):179-186. PubMed ID: 36055601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis.
    García-Azorín D; Do TP; Gantenbein AR; Hansen JM; Souza MNP; Obermann M; Pohl H; Schankin CJ; Schytz HW; Sinclair A; Schoonman GG; Kristoffersen ES
    J Headache Pain; 2021 Sep; 22(1):108. PubMed ID: 34535076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis.
    Castaldo M; Waliszewska-Prosół M; Koutsokera M; Robotti M; Straburzyński M; Apostolakopoulou L; Capizzi M; Çibuku O; Ambat FDF; Frattale I; Gadzhieva Z; Gallo E; Gryglas-Dworak A; Halili G; Jusupova A; Koperskaya Y; Leheste AR; Manzo ML; Marcinnò A; Marino A; Mikulenka P; Ong BE; Polat B; Popovic Z; Rivera-Mancilla E; Roceanu AM; Rollo E; Romozzi M; Ruscitto C; Scotto di Clemente F; Strauss S; Taranta V; Terhart M; Tychenko I; Vigneri S; Misiak B; Martelletti P; Raggi A;
    J Headache Pain; 2022 Mar; 23(1):41. PubMed ID: 35361131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in reporting embolic and thrombotic events after COVID-19 vaccination: A retrospective, pharmacovigilance study.
    Kan Y; Asada M; Uesawa Y
    PLoS One; 2022; 17(8):e0269268. PubMed ID: 35913955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
    Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
    JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.
    Wu S; Huang J; Zhang Z; Wu J; Zhang J; Hu H; Zhu T; Zhang J; Luo L; Fan P; Wang B; Chen C; Chen Y; Song X; Wang Y; Si W; Sun T; Wang X; Hou L; Chen W
    Lancet Infect Dis; 2021 Dec; 21(12):1654-1664. PubMed ID: 34324836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
    Saluja P; Gautam N; Yadala S; Venkata AN
    Thromb Res; 2022 Jun; 214():115-121. PubMed ID: 35533526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study.
    Göbel CH; Heinze A; Karstedt S; Morscheck M; Tashiro L; Cirkel A; Hamid Q; Halwani R; Temsah MH; Ziemann M; Görg S; Münte T; Göbel H
    Brain Commun; 2021; 3(3):fcab169. PubMed ID: 34405142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Headaches and facial pain attributed to SARS-CoV-2 infection and vaccination: a systematic review.
    Mitsikostas DD; Caronna E; De Tommaso M; Deligianni CI; Ekizoglu E; Bolay H; Göbel CH; Kristoffersen ES; Lampl C; Moro E; Pozo-Rosich P; Sellner J; Terwindt G; Irimia-Sieira P
    Eur J Neurol; 2024 Jun; 31(6):e16251. PubMed ID: 38415282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.